Trade Summary

3 months ago, Lynx1 Capital Management LP, serving as 10% owner at Passage Bio, Inc. (PASG), purchased 32,008 shares at $6.99 per share, for a total transaction value of $223,735.00. Following this transaction, Lynx1 Capital Management LP now holds 1,215,725 shares of PASG.

This purchase represents a 3.00% increase in Lynx1 Capital Management LP's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, September 11, 2025 and publicly disclosed via SEC Form 4 filing on Monday, September 15, 2025, 4 days after the trade was made.

Passage Bio, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.